Quantcast

Latest Breast cancer chemotherapy Stories

2009-11-11 02:00:00

Finland, November 11 /PRNewswire/ -- - This is a third party press release. It will be issued by the Finnish Breast Cancer Group on Wednesday 11 November 2009. - FinXX, a Large, Phase III Randomised Study in Women With Early Breast Cancer Shows that Adding Capecitabine (Xeloda(R)) to a Treatment Regimen Containing Standard Agents Allows More Women to Live Cancer-Free for Longer An analysis conducted by the Finnish Breast Cancer Group and published in The Lancet Oncology...

2009-07-06 14:03:19

 In a study to determine the non-medical factors that may be associated with the decision to treat nonmetastatic breast cancer, researchers at Columbia University Mailman School of Public Health evaluated the association between oncologist characteristics and the receipt of chemotherapy in elderly women with breast cancer and found that they were more likely to receive chemotherapy if treated by oncologists employed in a private practice. For elderly women with localized breast cancer...

2009-05-27 08:19:49

Research from the Northwestern University Feinberg School of Medicine has found that a less toxic, solvent-free chemotherapy drug more effectively prevents the progression of metastatic breast cancer and has fewer side effects than a commonly used solvent-based drug.A national study led by William Gradishar, M.D., director of breast medical oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, found that the drug Abraxane prolonged progression-free survival...

2009-05-14 13:07:35

Chemotherapy in addition to the surgery or surgery and radiation improves survival among older women with breast cancer, U.S. researchers said. Corresponding author Dr. Hyman Muss of the University of North Carolina at Chapel Hill said the study was conducted with 600 women via the National Cancer Institute's Clinical Trials Cooperative Group Program. The study, published in The New England Journal of Medicine, compared a combination of chemotherapy drugs -- the standard treatment -- to a...

2009-04-24 09:49:10

A new non-invasive technology may soon help doctors quickly determine if chemotherapy if effectively treating a cancer patient. Researchers at Duke University developed a technique to examine the patterns in which light bounces off cell surfaces, which they say may be able to assess chemotherapy's success in inducing cancer cell death. The researchers treated breast cancer cells in a dish with one of two standard chemotherapeutic agents, paclitaxel and doxorubicin. They then applied light to...

2008-09-05 15:00:07

To: MEDICAL EDITORS Contact: Andrea Brunais, West Virginia University Health Sciences Center News Service, +1-304-293-7087, brunaisa@wvuh.com MORGANTOWN, W.Va., Sept. 5 /PRNewswire-USNewswire/ -- Cancer patients have complained for years about the mental fog known as chemobrain. Now in animal studies at West Virginia University, researchers have discovered that injections of N-acetyl cysteine (NAC), an antioxidant, can prevent the memory loss that breast cancer chemotherapy drugs...

2008-09-04 12:00:07

Injections of N-acetyl cysteine, an antioxidant, can prevent the memory loss that breast cancer chemotherapy drugs sometimes induce, U.S. researchers said. Rats were given the commonly used chemotherapy drugs adriamycin and cyclophosphamide and while on the drugs, rats who were trained to prefer a light room to a dark room forgot their training. "When animals are treated with chemotherapy drugs, they lose memory," Gregory Konat said in a statement. "When we add N-acetyl cysteine during...

2008-08-13 21:00:10

By JOHN VON RADOWITZ A TREATMENT for brittle bones has a dramatic effect on breast cancer when combined with chemotherapy, research has shown. Scientists found that the two drugs acted together to slow down the growth of tumours. In mice given the therapy, growing breast tumours were almost stopped in their tracks. A clinical trial is now under way in the UK which could lead to the treatment becoming widely available to patients. Since both drugs are already well established, and only...

2008-08-13 18:00:12

By JOHN VON RADOWITZ A TREATMENT for brittle bones has a dramatic effect on breast cancer when combined with chemotherapy, research has shown. Scientists found that the two drugs acted together to slow down the growth of tumours. In mice given the therapy, growing breast tumours were almost stopped in their tracks. A clinical trial is now under way in the UK which could lead to the treatment becoming widely available to patients. Since both drugs are already well established this may...

2008-07-24 12:00:22

US-based biotechnology company Halozyme Therapeutics has reported positive pre-clinical animal efficacy data for its pegylated-rHuPH20 enzyme. The study showed that treatment of hormone resistant human prostate cancer in tumor bearing mouse models with intravenous pegylated-rHuPH20 enzyme (PEGPH20) in combination with the chemotherapeutic drugs, docetaxel (Taxotere) or liposomal doxorubicin (Doxil) resulted in a substantial increase in anti-tumor activity. The docetaxel combination...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related